These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28495545)

  • 21. A novel blood glucose regulation using TSK0-FCMAC: a fuzzy CMAC based on the zero-ordered TSK fuzzy inference scheme.
    Ting CW; Quek C
    IEEE Trans Neural Netw; 2009 May; 20(5):856-71. PubMed ID: 19304482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
    Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
    IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Method to generate a large cohort in-silico for type 1 diabetes.
    Orozco-López O; Rodríguez-Herrero A; Castañeda CE; García-Sáez G; Elena Hernando M
    Comput Methods Programs Biomed; 2020 Sep; 193():105523. PubMed ID: 32442845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing risk of closed loop control of blood glucose in artificial pancreas using fractional calculus.
    Ghorbani M; Bogdan P
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():4839-42. PubMed ID: 25571075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modelling the glucose-insulin system as a basis for the artificial beta cell.
    Fischer U; Salzsieder E; Jutzi E; Albrecht G; Freyse EJ
    Biomed Biochim Acta; 1984; 43(5):597-605. PubMed ID: 6383364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near-optimal feedback control for postprandial glucose regulation in type 1 diabetes.
    Sanz R; García P; Romero-Vivó S; Díez JL; Bondia J
    ISA Trans; 2023 Feb; 133():345-352. PubMed ID: 36116963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Artificial Pancreas Project at Cambridge 2013.
    Hovorka R
    Diabet Med; 2015 Aug; 32(8):987-92. PubMed ID: 25819473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical model of glucose-insulin homeostasis in healthy rats.
    Lombarte M; Lupo M; Campetelli G; Basualdo M; Rigalli A
    Math Biosci; 2013 Oct; 245(2):269-77. PubMed ID: 23911696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial connection between glucose sensing and insulin delivery: implications of peritoneal administration.
    Fischer U; Freyse EJ; Salzsieder E; Rebrin K
    Artif Organs; 1992 Apr; 16(2):151-62. PubMed ID: 10078237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A robust controller for insulin pumps based on H-infinity theory.
    Kienitz KH; Yoneyama T
    IEEE Trans Biomed Eng; 1993 Nov; 40(11):1133-7. PubMed ID: 8307597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closing the Loop on Exercise in Type 1 Diabetes.
    Bally L; Thabit H
    Curr Diabetes Rev; 2018; 14(3):257-265. PubMed ID: 28245784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose regulation and control of insulin and glucagon infusion using single model predictive control for type 1 diabetes mellitus.
    Crecil Dias C; Kamath S; Vidyasagar S
    IET Syst Biol; 2020 Jun; 14(3):133-146. PubMed ID: 32406378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis.
    Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M
    Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induced L₂-norm minimization of glucose-insulin system for Type I diabetic patients.
    Kovács L; Benyó B; Bokor J; Benyó Z
    Comput Methods Programs Biomed; 2011 May; 102(2):105-18. PubMed ID: 20674065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.